Skip to main content
US pharma giant seeks marketing authorisation from India for potential COVID-19 treatment drug - Moneycontrol 31-May-2020
US pharma giant seeks marketing authorisation from India for potential COVID-19 treatment drug - Moneycontrol
Gilead Sciences, who is the patent holder of the drug, has the complete data about the pre-clinical and clinical studies for remdesivir, sources said.
More...